3 recent notable approvals of medical AI

Along with AI, this ongoing list includes regulatory clearances of virtual and augmented reality, 3D printing and other emerging technologies targeted for healthcare.

1. DiA Imaging Analysis (Be’er Sheva, Israel, Oct. 29)—FDA 510(k) clearance for AI selection of optimal echocardiogram views. Product: LVivo Seamless

2. IQ-AI (Jersey, Channel Islands, Nov. 4)—FDA 510(k) clearance for software that uses AI to process CT scans for virtual liver biopsy of patients with chronic liver disease. Product: Liver Surface Nodularity/LSN

3. SenseTime (Abu Dhabi, UAI, Nov. 4)—CE certification for AI interpretation of CT scans with suspected lung diseases, including COVID-19. Product: SenseCare-Lung Pro

To see the previous entry in this series, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”